XM does not provide services to residents of the United States of America.
B
B

BuzziUnicem

Trade Ideas

Traders Sentiment

Technical Summary

Hourly

News

JPM cuts Buzzi to 'underweight' on overlooked risks to 2024 earnings

BUZZ-JPM cuts Buzzi to 'underweight' on overlooked risks to 2024 earnings ** J.P.Morgan cuts Buzzi BZU.MI to "underweight" from "neutral" citing "overlooked" risks to the Italian cement maker's FY earnings, with H1 results "likely to be a slow start" ** JPM expects Buzzi to report H1 EBITDA of 558 million euros ($607 million), down 3% on a reported
J
B

Adidas, Antofagasta, Buzzi

EUROPE RESEARCH ROUNDUP-Adidas, Antofagasta, Buzzi July 22 (Reuters) - Securities analysts revised their ratings and price targets on several European companies including Adidas, Antofagasta and Buzzi, on Monday. HIGHLIGHTS * Adidas ADSGN.DE : HSBC raises target price to EUR 300 from EUR 240 * Antofagasta ANTO.L : Peel Hunt raises to reduce from sell * Barry Callebaut AG BARN.S : Citigroup raises to buy from neutral * Buzzi BZU.MI : JP Morgan cuts to underweight from neutral * Solvay SOLB.BR : U
3
A
A
A
A
A
A
B
B
B
E
E
H
T
H
B
B

Italy - Factors to watch on July 22

Italy - Factors to watch on July 22 The following factors could affect Italian markets on Monday. Reuters has not verified the newspaper reports, and cannot vouch for their accuracy. New items are marked with (*). For a complete list of diary events in Italy please click on IT/DIA . POLITICS Italian Prime Minister Giorgia Meloni said she would still be able to work with Ursula von der Leyen despite her Brothers of Italy party having voted against a second term for the German as head of the Europ
E
I
L
U
B
Z
I
U

Adyen, AstraZeneca, Auto Trader

EUROPE RESEARCH ROUNDUP-Adyen, AstraZeneca, Auto Trader July 2 (Reuters) - Securities analysts revised their ratings and price targets on several European companies, including Adyen, AstraZeneca and Auto Trader, on Tuesday. HIGHLIGHTS * Adyen NV ADYEN.AS : Jefferies cuts target price to EUR 1,695 from EUR 1,821 * AstraZeneca AZN.L : Jefferies raises target price to 11,700p from 11,300p * Auto Trader AUTOA.L : Jefferies raises target price to 935p from 830p * Halma HLMA.L : HSBC raises target pri
3
A
A
A
B
C
C
C
E
E
E
G
H
R
S
S
V
A
A
A
A
A
B
N
N
S

No changes expected in Italy's blue chip index next week

No changes expected in Italy's blue chip index next week MILAN, May 29 (Reuters) - No changes are expected in the Italian blue-chip stock index FTSE Mib .FTMIB in a review at the start of June, while regional bank Banco Desio e della Brianza DESI.MI should join the Mid Cap index, replacing the technology company Saes Getters SAEI.MI , traders said on Wednesday.
A
B
B
I

Conditions

Popular Assets

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.